Skip to main content

Table 12 Generic brands pricing strategies in comparison to OB in Lebanon

From: Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon

Lebanon

Generics with available OB in the market

-30% of the OB price

  

Generics with no available OB in the market

Category 1

Country of origin: US, UK, Canada, France, Austria, Belgium, Sweden, Germany, Switzerland, Ireland, Norway, Denmark, Italy, Spain, Netherlands, Finland, Japan, and Australia

Price for the first three generics in each category is set based on Price Certificate presented at registration. Within 3 months of a new generic being registered, the price is revised to be the average price of all generics within the category. Price is also revised in case of price variation of any of the generics in the category.

Category 2

All other countries

Locally packaged generics (under license)

Price depends on the ex-factory price in the country of origin

In both cases, price should be 30% less than OB

Locally manufactured generics

Price depends on local ex-factory price